Table 2: Clinical characteristics of patients (n = 42).
| Clinical Characteristics | Number (n) | Frequency (%) | |
| Type of AKI | Acquired in community | 38 | 90 |
| Acquired in hospitalization | 4 | 10 | |
| Total | 42 | 100 | |
| Severity (KDIGO¶) | Stage 1 | 23 | 55 |
| 55 | 9 | 21 | |
| Stage 3 | 10 | 24 | |
| Total | 42 | 100 | |
| Etiological factors N (65) | Dehydration | 16 | 38 |
| Third space | 3 | 7 | |
| Heart failure | 2 | 5 | |
| Sepsis | 23 | 55 | |
| Hypercalcemia | 2 | 5 | |
| Functional drug | 1 | 2 | |
| Malignant HBP* | 6 | 14 | |
| Nephrotoxic drugs | 2 | 5 | |
| Ischemic tubular necrosis | 3 | 7 | |
| Toxic tubular necrosis | 2 | 5 | |
| Bilateral pyelonephritis | 2 | 5 | |
| Glomerulonephritis | 1 | 2 | |
| Obstructive causes | 1 | 2 | |
| Comorbidities | Diabetes | 6 | 14 |
| HBP | 13 | 31 | |
| Malignant neoplasia | 5 | 12 | |
| Any | 8 | 19 | |
| Cirrhosis | 4 | 10 | |
| Other | 3 | 7 | |
| HIV$ | 3 | 7 | |
| Total | 42 | 100 | |
| Dialysis rate | Dialysis | 4 | 9.5 |
| No dialysis | 38 | 90.5 | |
| Total | 42 | 100 | |
*HBP: High blood pressure; ¶KDIGO: Kidney disease Improving global outcomes; $HIV: Human immunodeficiency virus.